Washington COVID-19 biorepository expands sample types
Seattle – September 29, 2020 – Recently expanded to support diagnostics developers earlier in the development cycle, the Washington COVID-19 biorepository now includes convalescent plasma to accelerate the development of antibody assays. The current pandemic showcases a critical need to accelerate the development and validation of quality diagnostic products for COVID-19. To support this effort,…
Details